Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Spinocerebellar Degenerations

• A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
• STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
• A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
• Chinese Medicine WT for Spinocerebellar Ataxia Type 3
• Study of CAD-1883 for Spinocerebellar Ataxia
• C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
• Troriluzole in Adult Subjects With Spinocerebellar Ataxia
• Riluzole in Patients With Spinocerebellar Ataxia Type 7
• An Open Pilot Trial of BHV-4157
• Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)
• Trial in Adult Subjects With Spinocerebellar Ataxia
• An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
• Study To Assess Safety, Tolerability and Efficacy of Intravenous Cabaletta in Patients With Machado-Joseph Disease
• A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• A Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• Dalfampridine and Gait in Spinocerebellar Ataxias
• A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• Efficacy of Riluzole in Hereditary Cerebellar Ataxia
• Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
• Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
• A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
• Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
• Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
• Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
• Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
• High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration